Visit
At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, from Istituto Europeo di Oncologia, Milan, Italy, explains that genetic differences between primary and metastatic breast cancer may have important clinical implications, including for the identification of biomarkers in disease progression.
VJOncology is intended for Healthcare Professionals onlyBy choosing to continue, you are confirming that you are a healthcare professional
VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.
